These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12907206)

  • 1. Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes.
    Kacani L; Wurm M; Schennach H; Braun I; Andrle J; Sprinzl GM
    Oral Oncol; 2003 Oct; 39(7):672-9. PubMed ID: 12907206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
    Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
    Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
    Younis RH; Han KL; Webb TJ
    J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors.
    Bailet JW; Lichtenstein A; Chen G; Mickel RA
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):855-62. PubMed ID: 9260552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.
    Moy JD; Moskovitz JM; Ferris RL
    Eur J Cancer; 2017 May; 76():152-166. PubMed ID: 28324750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
    Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
    Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional alteration of myeloid dendritic cells through head and neck cancer.
    Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
    Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells.
    Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid metabolite expression by head and neck squamous cell carcinoma.
    Mann EA; Spiro JD; Chen LL; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):763-9. PubMed ID: 8018329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.
    Schuler PJ; Börger V; Bölke E; Habermehl D; Matuschek C; Wild CA; Greve J; Bas M; Schilling B; Bergmann C; Trellakis S; Budach W; Gauler T; Brandau S; Lang S; Whiteside TL; Sorg RV; Hoffmann TK
    Eur J Med Res; 2011 Feb; 16(2):57-62. PubMed ID: 21463982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
    Strauss L; Volland D; Kunkel M; Reichert TE
    Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
    Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor modulation in head and neck cancer.
    Pries R; Wulff S; Wollenberg B
    Crit Rev Immunol; 2008; 28(3):201-13. PubMed ID: 19024345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic consequences of signal transducers and activators of transcription 3 activation in human squamous cell carcinoma.
    Albesiano E; Davis M; See AP; Han JE; Lim M; Pardoll DM; Kim Y
    Cancer Res; 2010 Aug; 70(16):6467-76. PubMed ID: 20682796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells and HNSCC: a potential treatment option? (Review).
    Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
    Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
    Penna G; Adorini L
    J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma.
    Sánchez-Rodríguez C; Cruces KP; Riestra Ayora J; Martín-Sanz E; Sanz-Fernández R
    Vaccine; 2017 Nov; 35(47):6395-6403. PubMed ID: 29029943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
    Young MR; Wright MA; Pandit R
    J Immunol; 1997 Jul; 159(2):990-6. PubMed ID: 9218621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.